Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Lymphoma 18Lymphoma, Large B-Cell, Diffuse 12Lymphoma, Non-Hodgkin 9Lymphoma, B-Cell, Marginal Zone 4Leukemia 4Lymphoma, Mantle-Cell 3Lymphoma, Follicular 3Hodgkin Disease 3Waldenstrom Macroglobulinemia 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Nausea 2Leukemia, Lymphocytic, Chronic, B-Cell 2Vomiting 1Orbital lymphoma 1Myelodysplastic Syndromes 1Myasthenia Gravis 1Lymphoma, T-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large-Cell, Anaplastic 1Immunoblastic Lymphadenopathy 1Central Nervous System Neoplasms 1Burkitt Lymphoma 1

Interventions

Aprepitant 8Dexamethasone 7Calcium Dobesilate 7Ondansetron 6dexamethasone acetate 5Therapeutics 5Doxorubicin 5Vincristine 4Palonosetron 4Cyclophosphamide 4dexamethasone 21-phosphate 3Psychiatric Rehabilitation 3Granisetron 3peppermint oil 2auricularum 2Yoga 2Rituximab 2Music Therapy 2Mesna 2Lorazepam 2Ifosfamide 2Control Groups 2Aromatherapy 2Acupressure 2stinging nettle lectin 1salicylhydroxamic acid 1fosaprepitant 1dolasetron 1almond oil 1Whole Body Imaging 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Nausea × Rituximab × Clear all
NCT01843868 2024-08-07

Emesis Control Study in Non-Hodgkin Lymphoma Patients Receiving R-CHOP

Australasian Leukaemia and Lymphoma Group

Phase NA Withdrawn
Lymphoid

Lymphoma, Lymphoma, Non-Hodgkin, Nausea, Vomiting

NCT00651755 2013-07-02

Aprepitant's Effect on Drug Metabolism in Multi-Day Combination (CHOP/R-CHOP) Chemotherapy Regimen in Lymphoma Patients

M.D. Anderson Cancer Center

Phase NA Completed
23 enrolled 14 charts
Lymphoid

Lymphoma, Lymphoma, Non-Hodgkin, Nausea

Data powered by HemOnc (CC BY 4.0) Colophon âš¡